SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of acquisition of beneficial ownership by individuals:
SEC Accession No. 0001079973-19-000359
Filing Date
2019-06-17
Accepted
2019-06-17 17:01:47
Documents
1
Group Members
IBEX GP LLCIBEX INVESTMENT HOLDINGS II LLCIBEX INVESTMENT HOLDINGS LLCIBEX ISRAEL FUND LLLPJUSTIN B. BORUS

Document Format Files

Seq Description Document Type Size
1 SCHEDULE 13G ibex_13g-redhill.htm SC 13G 158608
  Complete submission text file 0001079973-19-000359.txt   160353
Mailing Address 3200 CHERRY CREEK SOUTH DRIVE SUITE 670 DENVER CO 80209
Business Address 3200 CHERRY CREEK SOUTH DRIVE SUITE 670 DENVER CO 80209 303-500-8821
Ibex Investors LLC (Filed by) CIK: 0001531964 (see all company filings)

IRS No.: 331042318 | State of Incorp.: CO | Fiscal Year End: 1231
Type: SC 13G

Mailing Address 21 HA'ARBA'A STREET TEL AVIV L3 64739
Business Address 21 HA'ARBA'A STREET TEL AVIV L3 64739 972-3-541-3131
RedHill Biopharma Ltd. (Subject) CIK: 0001553846 (see all company filings)

IRS No.: 000000000 | State of Incorp.: L3
Type: SC 13G | Act: 34 | File No.: 005-87280 | Film No.: 19901985
SIC: 2834 Pharmaceutical Preparations